Alzheimer’s disease has long been a puzzle for scientists and doctors. It’s a condition where people slowly lose their memory and ability to think or make decisions.
Researchers have been working hard to understand it better and find effective treatments.
Now, a team of Dutch scientists has made a groundbreaking discovery: there are actually five different types of Alzheimer’s disease. This finding could change the way we approach treatment for this challenging disease.
The team, including researcher Betty Tijms from the Alzheimer Center Amsterdam and elsewhere, published their study in Nature Aging. They’ve found that not all Alzheimer’s cases are the same.
Up until now, most people thought Alzheimer’s was mostly about two proteins, amyloid and tau, building up in the brain. But it turns out there’s more to the story.
The researchers used new methods to study the cerebrospinal fluid – the fluid that surrounds the brain and spinal cord – in people with Alzheimer’s.
They examined a whopping 1,058 proteins in the fluid from 419 people with the disease. And they discovered something surprising: there are five different biological versions of Alzheimer’s.
Let’s break these down a bit. The first type is where the body makes too much amyloid. In the second type, there’s a problem with the blood-brain barrier (a kind of filter that protects the brain), less amyloid is made, and nerve cells don’t grow as they should.
The differences don’t stop there. Each type also varies in how much protein it makes, how the immune system works, and how the organ that creates the cerebrospinal fluid functions.
People with different types of Alzheimer’s also experience the disease differently. Some types might lead to a faster progression of the disease than others.
Why is this important? Well, it could explain why some Alzheimer’s drugs haven’t worked as well as hoped. A drug that might be helpful for one type of Alzheimer’s could be less effective or even harmful for another type.
For instance, a medicine that slows down amyloid production could be good for the type that makes too much amyloid but not for the type that makes too little.
This discovery could change the way we look at treating Alzheimer’s. It’s like realizing that not everyone with a cough has the same illness; some might have a cold, while others might have something more serious like pneumonia.
The same idea applies to Alzheimer’s now. Understanding that there are different types can help scientists develop more targeted and effective treatments.
The researchers are now planning to see if these Alzheimer’s types really do respond differently to medications.
This could be a big step toward providing better, more personalized treatment for everyone with Alzheimer’s in the future. It’s an exciting development in the fight against a disease that affects millions of people and their families around the world.
If you care about Alzheimer’s, please read studies about Vitamin D deficiency linked to Alzheimer’s, vascular dementia, and Oral cannabis extract may help reduce Alzheimer’s symptoms.
For more information about brain health, please see recent studies about Vitamin B9 deficiency linked to higher dementia risk, and results showing flavonoid-rich foods could improve survival in Parkinson’s disease.
The research findings can be found in Nature Aging.
Copyright © 2024 Knowridge Science Report. All rights reserved.
